Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Friday, May 30, 2025 · 817,442,469 Articles · 3+ Million Readers

Global Uncomplicated Urinary Tract Infection Market Set For 6.8% Growth, Reaching $14.27 Billion By 2029

Uncomplicated Urinary Tract Infection Global Market Report 2025

Uncomplicated Urinary Tract Infection Global Market Report 2025

The Business Research Company's Uncomplicated Urinary Tract Infection Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034

The Business Research Company’s Latest Report Explores Market Driver, Trends, Regional Insights - Market Sizing & Forecasts Through 2034”
— The Business Research Company

LONDON, GREATER LONDON, UNITED KINGDOM, May 29, 2025 /EINPresswire.com/ -- The uncomplicated urinary tract infection market has experienced considerable growth in recent years. The market grew from $10.24 billion in 2024 to $10.98 billion in 2025, reflecting a robust compound annual growth rate CAGR of 7.2%. The historic period saw growth fueled by the rising incidences of renal failure and bladder cancer, an increase in chronic kidney diseases, and more extensive use of urinary catheters. The prevalence of diabetes also played a significant role in driving market growth.

Where Is The Uncomplicated Urinary Tract Infection Market Headed In The Future?
The market size of uncomplicated urinary tract infection treatments is slated for impressive growth in the coming years, with projections of the market reaching $14.27 billion in 2029, registering a CAGR of 6.8%. This growth during the forecast period is expected to be driven by factors such as rising bacterial infections, an increasing aging population, and higher rates of urinary tract infections. The increased use of contraceptives and a rise in sexual activity are other key contributory factors. Looking ahead, trends that will shape the market landscape include the development of telemedicine and telehealth solutions, advancements in therapeutics for UTI, and the development of novel drugs.

Get Your Free Sample Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=23550&type=smp

What's Fueling The Uncomplicated Urinary Tract Infection Market Growth?
In particular, the increasing incidence of chronic kidney diseases is expected to be a major driver of the uncomplicated urinary tract infection market. Chronic kidney disease, a long-term condition marked by the gradual loss of kidney function, leads to waste and fluid build-up in the body, leaving individuals more susceptible to urinary tract infections. These chronic ailments also result in a weaker immune system, which in turn contributes to an environment conducive to bacterial growth.

Interestingly, the rising cases of diabetes are also fueling market growth. Diabetes, a chronic disorder characterized by high blood sugar levels due to insufficient insulin production or ineffective insulin utilization, creates a favorable environment for bacterial growth in the urinary tract and thereby increases susceptibility to urinary tract infections.

Which Companies Form The Backbone Of The Uncomplicated Urinary Tract Infection Market?
Multiple industry players are bolstering the uncomplicated urinary tract infection market. Prominent companies include Cardinal Health, Pfizer Inc., Bayer AG, AstraZeneca plc, GSK plc, Eli Lilly and Company, Siemens AG, Strykar Healthcare, John Hopkins Medicine, Shionogi & Co. Ltd., Sysmex Corporation, Bio-Rad Laboratories Inc, Cipla Inc., UTILITY therapeutics Ltd, Orchid Pharma Limited, ACON Labs, Sonika Lifesciences, Emergency Care BC, EB Medicine, and Iterum Therapeutics PLC.

What Trends Are Emerging In The Uncomplicated Urinary Tract Infection Market?
These enterprises are innovating in antibiotic development to bolster treatment effectiveness and combat antibiotic-resistant bacteria. An example of such an innovation is the recent FDA approval of Pivya pivmecillinam tablets, intended for treating female adults with uncomplicated urinary tract infections resulting from susceptible bacteria.

Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/uncomplicated-urinary-tract-infection-global-market-report

How Is The Market Of The Uncomplicated Urinary Tract Infection Segmented?
The uncomplicated urinary tract infection market, as extensively detailed in the report, is segmented and subsegmented as follows:
1 By Test Type: Urinalysis, Urine Cultures, Susceptibility Testing
2 By Drug: Penicillin And Combinations, Quinolones, Cephalosporin, Azoles And Amphotericin B, Nitrofurans, Other Drugs
3 By End-Users: Hospitals, Diagnostic Labs, Research Institutes
Subsegments:
1 By Urinalysis: Dipstick Tests, Microscopic Examination, Automated Urinalysis
2 By Urine Cultures: Agar Plate Culture, Broth Culture, Chromogenic Media
3 By Susceptibility Testing: Disk Diffusion Method, Automated Susceptibility Testing, Molecular Susceptibility Testing

What Regional Trends Are Shaping The Uncomplicated Urinary Tract Infection Market?
In 2024, North America was the largest region in the uncomplicated urinary tract infection market. The regions that the report covers include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Browse For More Similar Reports-

Hospital-Acquired Infection Control Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/hospital-acquired-infection-control-global-market-report

UV Disinfection Equipment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/uv-disinfection-equipment-global-market-report

Pseudomonas Aeruginosa Infection Treatment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/pseudomonas-aeruginosa-infection-treatment-global-market-report

About The Business Research Company
Learn more about The Business Research Company, a globally recognized industry leader with more than 15000+ reports spanning 27 industries and 60+ geographies. With a reputation built on comprehensive, data-rich research backed by 1,500,000 datasets, unique in-depth secondary research and insights from industry leaders, The Business Research Company empowers businesses to stay ahead of the game.

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X

Powered by EIN Presswire

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry, International Organizations, Manufacturing, World & Regional

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Submit your press release